Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | PTPRC | P08575 | 1/20 | 0.30 |
| ▸ | CDC25B | P30305 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1162496 | 0.83 | TRPV4 (0.36) | TRPV4ALDH1A1HSD17B10TDP1 | |
| SCHEMBL562866 | 0.80 | TSHR (0.38) | ALDH1A1PTPRCCDC25B | |
| Benzene SCHEMBL28228273 | 0.78 | TSHR (0.36) | ALDH1A1 | |
| SCHEMBL1162373 | 0.77 | ALDH1A1 (0.39) | TRPV4ALDH1A1HSD17B10TDP1 | |
| SCHEMBL2763038 | 0.74 | ADRA2A (0.33) | ALDH1A1 | |
| SCHEMBL2526800 | 0.73 | SLC6A2 (0.31) | ALDH1A1 | |
| SCHEMBL1415493 | 0.73 | L3MBTL1 (0.46) | TRPV4ALDH1A1HSD17B10TDP1 | |
| SCHEMBL8087531 | 0.72 | ALDH1A1 (0.44) | ALDH1A1HSD17B10TDP1 | |
| SCHEMBL1765857 | 0.72 | TSHR (0.53) | ALDH1A1HSD17B10 | |
| SCHEMBL28332142 | 0.72 | CA1 (0.41) | ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8871668-B2 | Immobilized lewis acid catalysts coated with ionic liquids and use thereof | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2014-10-28 | — | — | US | disclosed |
| EP-1997555-B1 | IMMOBILIZED LEWIS ACID CATALYSTS COATED WITH IONIC LIQUIDS AND USE THEREOF | JAPAN SCIENCE & TECH AGENCY (JP) | 2013-02-27 | — | — | EP | disclosed |
| US-20090318729-A1 | IMMOBILIZED LEWIS ACID CATALYSTS COATED WITH IONIC LIQUIDS AND USE THEREOF | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2009-12-24 | — | — | US | disclosed |
| EP-1997555-A1 | IMMOBILIZED LEWIS ACID CATALYSTS COATED WITH IONIC LIQUIDS AND USE THEREOF | Japan Science and Technology Agency (JP) | 2008-12-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318729-A1 | IMMOBILIZED LEWIS ACID CATALYSTS COATED WITH IONIC LIQUIDS AND USE THEREOF | SELL, LCT, LDHA | TRPV4 4033/4885ALDH1A1 731/4885HSD17B10 4283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.